MEDIA ALERT: DENVER/June 27, 2024 — Morris Animal Foundation has announced the approval of funding for two new studies focused on immune-mediated hemolytic anemia, a deadly blood disorder of dogs.
"We’re very excited to fund these projects," said Dr. Kelly Diehl, Senior Director of Science Communication at Morris Animal Foundation. "Thanks to support from Allen and Barbara Dearry, we hope to make a significant difference in the understanding and treatment of this important but underfunded disease.”
Allen and Barbara Dearry were inspired to tackle the disease by their young whippet, Clark, who is living through his diagnosis of IMHA after a year of significant interventions. More information on Clark’s IMHA journey is available on the Foundation’s website. The Dearrys hope their support of this much-needed IMHA research will help dogs and dog owners everywhere have lives free of this uncommon but deadly disease.
Grant recipients, and a brief summary of their projects, are:
- Dr. Barbara Glanemann, Royal Veterinary College, United Kingdom — Researchers will assess how the immune system goes wrong in dogs with IMHA, and the team will study how individual dogs respond to medications currently available for treatment.
- Dr. Steven Friedenberg, University of Minnesota, Dr. Dana LeVine, Auburn University and Dr. Austin Viall, University of California, Davis — Researchers will study whether there are subtypes of IMHA and whether those subtypes have different prognoses and optimal therapy.
About Morris Animal Foundation
Morris Animal Foundation's mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, it is one of the largest nonprofit animal health research organizations in the world, funding nearly $160 million in more than 3,000 critical animal health studies to date across a broad range of species. Learn more at morrisanimalfoundation.org.
Media Contact: Lindsey Washington
